Steven Pieper Net Worth & Insider Trades
Steven Pieper - See Remarks, Xeris Biopharma Holdings, Inc
What is Steven Pieper's Net Worth?
The current estimated net worth of Xeris Biopharma Holdings, Inc's See Remarks, Steven Pieper, is estimated to be about $413.03K . Steven Pieper owns about 183,108 units of Xeris Biopharma Holdings, Inc common stock. In the last 2 years at Xeris Biopharma Holdings, Inc, Steven Pieper has sold an estimated value of $0 worth.
What is Steven Pieper's Past Insider Trading?
Steven Pieper's largest purchase order was 25,000 units , worth over $49.92K on November 12, 2021. In total, Steven Pieper has made about 6 transactions over 2 years of their time at Xeris Biopharma Holdings, Inc. Steven Pieper usually trades in October, with the busiest year in 2021.
Steven Pieper
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Steven Pieper's' Mailing Address?
- Mailing address is Xeris Pharmaceuticals, Inc. 180 N. Lasalle Street, Suite 1600 Chicago IL 60601 IL
Xeris Biopharma Holdings, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Paul Edick, | 2020 | $626,977 | $1,178,450 | - | $453,222 | $5,700 | $2,264,349 |
| Paul Edick, | 2019 | $598,277 | $1,735,000 | $1,598,580 | $370,181 | $5,600 | $4,307,638 |
| John Shannon, | 2020 | $473,658 | $414,050 | $246,300 | $300,000 | $2,420 | $1,436,428 |
| John Shannon, | 2019 | $444,479 | - | $639,432 | $178,500 | $5,171 | $1,267,582 |
| Beth Hecht, | 2020 | $392,852 | $286,650 | $369,450 | $189,808 | $5,634 | $1,244,394 |
| Beth Hecht, | 2019 | $364,417 | - | $259,769 | $145,782 | $5,600 | $775,568 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1346302/000134630221000036/a2021proxystatement.htm
What are Xeris Biopharma Holdings, Inc's Past Insider Trades?
Xeris Biopharma Holdings, Inc's most recent insider trade came on December 14, 2022 by Paul Edick who bought 20,000 units worth $29K . In the last 4 years, insiders at Xeris Biopharma Holdings, Inc have sold an estimated value of $3.18M and bought an estimated value of $31.36M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Steven Prestrelski, Chief Scientific Officer, Paul Edick, See Remarks, and Patrick John Shannon Jr, See Remarks .
XERIS PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||